Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 10-2016 | 07-2016 | 04-2016 | 01-2016 | 10-2015 | |
| Sales | 263 | 248 | 145 | 268 | 185 |
| Cost of Goods | 117 | 108 | 109 | 179 | 78 |
| Gross Profit | 146 | 140 | 36 | 89 | 106 |
| Operating Expenses | 144 | 159 | 124 | 107 | 209 |
| Operating Income | 2 | -19 | -88 | -18 | -102 |
| Interest Expense | 6 | 5 | 2 | 2 | 0 |
| Other Income | 13 | -9 | 6 | 1 | -17 |
| Pre-tax Income | 8 | -33 | -84 | -20 | -119 |
| Net Income Continuous | 8 | -33 | -84 | -20 | -119 |
| Net Income | $8 | $-33 | $-84 | $-20 | $-119 |
| EPS Basic Total Ops | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Basic Continuous Ops | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted Total Ops | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted Continuous Ops | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EBITDA(a) | $26 | $-17 | $-70 | $-6 | $-105 |